D-Rd in transplant-ineligible newly diagnosed myeloma: MAIA long-term outcomes D-Rd in transplant-ineligible newly diagnosed myeloma: MAIA long-term outcomes April 2025 Clinical trials Read more
2022 March Clinical trials POLARIX: Pola-R-CHP versus R-CHOP in patients with previously untreated DLBCL Read more
2022 March Clinical practice Eltrombopag added to immunosuppression improves haematologic response among patients with seve... Read more
2022 January Editor's pick RELEVANT LITERATURE FOR YOUR DAILY PRACTICE SELECTED BY: NIKKI GRANACHER Read more
2022 January Clinical trials Asciminib as a new treatment option in later-line chronic myeloid leukaemia in chronic phase Read more
2022 January Clinical practice Dose optimisation of ponatinib in patients with resistant chronic-phase CML Read more
2022 January Clinical practice MRD-driven treatment discontinuation with obinutuzumab, venetoclax and zanubrutinib in frontli... Read more
Top
